Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Cell Reports. Medicine
|
March 7, 2026
Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease
Paula Nieto, Svenja Klinsing, Ginevra Caratù, et al.
Acta Neuropathologica
|
September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma
Daniel Picard, Jörg Felsberg, Maike Langini, et al.
Cancer Immunology Research
|
October 11, 2019
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
Mariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, et al.
EMBO Molecular Medicine
|
December 16, 2015
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
Alexander Scholz, Patrick N Harter, Sebastian Cremer, et al.
Basic Research in Cardiology
|
January 26, 2023
The endothelial-enriched lncRNA LINC00607 mediates angiogenic function
Frederike Boos, James A Oo, Timothy Warwick, et al.
Circulation
|
March 30, 2017
Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function
Matthias S Leisegang, Christian Fork, Ivana Josipovic, et al.
Neuro-Oncology
|
May 6, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
Michael C Burger, Marie-Therese Forster, Annette Romanski, et al.
Acta Neuropathologica
|
February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA
Yanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Acta Neuropathologica
|
June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytoma
Maja Krech, Amos Muench, Daniel Teichmann, et al.
Nature Medicine
|
July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Lukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Cell Reports. Medicine
|
March 7, 2026
Integrative CSF profiling identifies disease-specific immune responses in leptomeningeal disease
Paula Nieto, Svenja Klinsing, Ginevra Caratù, et al.
Acta Neuropathologica
|
September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma
Daniel Picard, Jörg Felsberg, Maike Langini, et al.
Cancer Immunology Research
|
October 11, 2019
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF
Mariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, et al.
EMBO Molecular Medicine
|
December 16, 2015
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma
Alexander Scholz, Patrick N Harter, Sebastian Cremer, et al.
Basic Research in Cardiology
|
January 26, 2023
The endothelial-enriched lncRNA LINC00607 mediates angiogenic function
Frederike Boos, James A Oo, Timothy Warwick, et al.
Circulation
|
March 30, 2017
Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function
Matthias S Leisegang, Christian Fork, Ivana Josipovic, et al.
Neuro-Oncology
|
May 6, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma
Michael C Burger, Marie-Therese Forster, Annette Romanski, et al.
Acta Neuropathologica
|
February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA
Yanghao Hou, Jorge Pinheiro, Felix Sahm, et al.
Acta Neuropathologica
|
June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytoma
Maja Krech, Amos Muench, Daniel Teichmann, et al.
Nature Medicine
|
July 11, 2018
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Lukas Bunse, Stefan Pusch, Theresa Bunse, et al.
Page
of 10